Management Strategies in Facioscapulohumeral Muscular Dystrophy

Overview

Journal Intractable Rare Dis Res

Date 2019 Mar 19

PMID 30881851

Citations 4

Authors

Junren Lu

Zhenjun Yao

Yi Yang

Chi Zhang

Jian Zhang

Ying Zhang

Affiliations

Soon will be listed here.

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) also known as Landouzy-Dejerine disease, is an autosomal-dominant disorder of the skeletal muscles with the name according to the various muscle groups it affects: the face, shoulders and upper arms. It is the third most common genetic degenerative disorder of the skeletal muscles without specific patterns in all the affected individuals. At present there is no cure for the disease but numerous management strategies are available to improve the quality of life and prevent further degeneration of various muscle groups. This review aims to provide an insight on the management strategies for FSHD patients including both lifestyle and medical intervention.

Citing Articles

Combined Lumbar-Sacral Plexus Block in Facioscapulohumeral Muscular Dystrophy for Hip Fracture Surgery: A Case Report.

Manici M, Kalyoncu I, Gedik C, Deveci M, Gurkan Y Turk J Anaesthesiol Reanim. 2024; 52(1):36-38.

PMID: 38414180 PMC: 10901043. DOI: 10.4274/TJAR.2024.231471.

Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.

Statland J, Campbell C, Desai U, Karam C, Diaz-Manera J, Guptill J Muscle Nerve. 2022; 66(1):50-62.

PMID: 35428982 PMC: 9321022. DOI: 10.1002/mus.27558.

DUX4 Transcript Knockdown with Antisense 2'-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular Dystrophy.

Lim K, Bittel A, Maruyama R, Echigoya Y, Nguyen Q, Huang Y Mol Ther. 2020; 29(2):848-858.

PMID: 33068777 PMC: 7854280. DOI: 10.1016/j.ymthe.2020.10.010.

DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD.

Klingler C, Ashley J, Shi K, Stiefvater A, Kyba M, Sinnreich M FASEB J. 2020; 34(3):4573-4590.

PMID: 32020675 PMC: 7079142. DOI: 10.1096/fj.201902696.

References

Sposito R, Pasquali L, Galluzzi F, Rocchi A, Solito B, Soragna D . Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study. Genet Test. 2005; 9(1):30-6. DOI: 10.1089/gte.2005.9.30. View

Rhee Y, Ha J . Long-term results of scapulothoracic arthrodesis of facioscapulohumeral muscular dystrophy. J Shoulder Elbow Surg. 2006; 15(4):445-50. DOI: 10.1016/j.jse.2005.10.015. View

Tawil R . Facioscapulohumeral muscular dystrophy. Neurotherapeutics. 2008; 5(4):601-6. PMC: 2628543. DOI: 10.1016/j.nurt.2008.07.005. View

FitzSimons R, Gurwin E, Bird A . Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain. 1987; 110 ( Pt 3):631-48. DOI: 10.1093/brain/110.3.631. View

Rudnik-Schoneborn S, Glauner B, Rohrig D, Zerres K . Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch Neurol. 1997; 54(7):888-94. DOI: 10.1001/archneur.1997.00550190076017. View

Olsen D, Orngreen M, Vissing J . Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology. 2005; 64(6):1064-6. DOI: 10.1212/01.WNL.0000150584.45055.27. View

Laforet P, De Toma C, Eymard B, Becane H, Jeanpierre M, Fardeau M . Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology. 1998; 51(5):1454-6. DOI: 10.1212/wnl.51.5.1454. View

Giannini S, Faldini C, Pagkrati S, Grandi G, Digennaro V, Luciani D . Fixation of winged scapula in facioscapulohumeral muscular dystrophy. Clin Med Res. 2007; 5(3):155-62. PMC: 2111408. DOI: 10.3121/cmr.2007.736. View

Kissel J . Facioscapulohumeral dystrophy. Semin Neurol. 2000; 19(1):35-43. DOI: 10.1055/s-2008-1040824. View

10.

Wohlgemuth M, van der Kooi E, van Kesteren R, van der Maarel S, Padberg G . Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology. 2004; 63(1):176-8. DOI: 10.1212/01.wnl.0000133126.86377.e8. View

11.

Padberg G, Brouwer O, de Keizer R, Dijkman G, Wijmenga C, Grote J . On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve Suppl. 2013; (2):S73-80. View

12.

Jordan B, Eger K, Koesling S, Zierz S . Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol. 2010; 258(5):866-73. DOI: 10.1007/s00415-010-5858-z. View

13.

Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S . Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol. 2003; 60(10):1421-5. DOI: 10.1001/archneur.60.10.1421. View

14.

Tawil R, van der Maarel S, Padberg G, van Engelen B . 171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2010; 20(7):471-5. DOI: 10.1016/j.nmd.2010.04.007. View

15.

Lemmers R, Tawil R, Petek L, Balog J, Block G, Santen G . Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 2012; 44(12):1370-4. PMC: 3671095. DOI: 10.1038/ng.2454. View

16.

Trevisan C, Pastorello E, Armani M, Angelini C, Nante G, Tomelleri G . Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia. Eur Neurol. 2006; 56(1):1-5. DOI: 10.1159/000094248. View

17.

Eger K, Jordan B, Habermann S, Zierz S . Beevor's sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. J Neurol. 2009; 257(3):436-8. DOI: 10.1007/s00415-009-5342-9. View

18.

Tawil R, van der Maarel S . Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006; 34(1):1-15. DOI: 10.1002/mus.20522. View

19.

Kilmer D, Abresch R, McCrory M, Carter G, FOWLER Jr W, Johnson E . Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 1995; 74(5 Suppl):S131-9. DOI: 10.1097/00002060-199509001-00007. View

20.

Deenen J, Arnts H, van der Maarel S, Padberg G, Verschuuren J, Bakker E . Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014; 83(12):1056-9. PMC: 4166358. DOI: 10.1212/WNL.0000000000000797. View